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Abstract Respiratory syncytial virus (RSV) is a cause of
neurological complications in infants. We report a rare case
of RSV encephalopathy in an infant who presented with
poor sucking and hypothermia at 17 days of age after
suffering from rhinorrhea and a cough for several days.
After hospitalization, the patient presented with stupor and
hypotonia lasting for at least 24 h, and was intubated,
sedated, and ventilated for treatment of pneumonia. These
symptoms led to diagnosis of pediatric systemic inﬂam-
matory response syndrome (SIRS) caused by RSV infec-
tion. High-dose steroid therapy was combined with
artiﬁcial ventilation because the initial ventilation therapy
was ineffective. Interleukin (IL)-6 levels in spinal ﬂuid
were markedly increased upon admission, and serum IL-6
and IL-8 levels showed even greater elevation. The patient
was diagnosed with RSV encephalopathy. On day 5, high
signal intensity in the bilateral hippocampus was observed
on diffusion-weighted magnetic resonance imaging (MRI).
On day 14, the patient presented with delayed partial sei-
zure and an electroencephalogram showed occasional
unilateral spikes in the parietal area, but the hippocampal
abnormality had improved to normal on MRI. 99mTc-
labeled ethylcysteinate dimer single-photon emission
computed tomography (SPECT) on day 18 showed hypo-
perfusion of the bilateral frontal and parietal regions and
the unilateral temporal region. SPECT at 3 months after
onset still showed hypoperfusion of the bilateral frontal
region and unilateral temporal region, but hypoperfusion of
the bilateral parietal region had improved. The patient has
no neurological deﬁcit at 6 months. These ﬁndings suggest
that RSV encephalopathy with cytokine storm induces
several symptoms and complications, including SIRS and
prolonged brain hypoperfusion on SPECT.
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Introduction
Infection with respiratory syncytial virus (RSV) causes
bronchitis, bronchiolitis, and pneumonia, and leads to
neurological complications in 1.8 % of cases [1]. These
neurological complications include RSV encephalopathy
[2, 3], the cause of which remains unclear. Kawashima
et al. [4] deﬁned three pathogenic types of RSV encepha-
lopathy characterized by metabolic error, excitotoxicity,
and cytokine storm. Here, we describe a rare case of a
neonate with RSV encephalopathy of the cytokine storm
type, which involved development of pediatric systemic
inﬂammatory response syndrome (SIRS) and prolonged
hypoperfusion lesions on brain single-photon emission
computed tomography (SPECT) without neurological
sequelae.
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Case report
The patient was a male infant born at 39 weeks gestation
(birth weight, 3,562 g). At this time, his brother and cousin
both had a cold, and the patient presented with rhinorrhea
and cough after several days. At 17 days of age, his parents
brought him to the emergency department because of poor
sucking for more than half a day and hypothermia
(33.0 C). The patient was in a continuous stupor with
hypotonia and did not respond to pain. He presented with
cyanosis, and percutaneous oxygen saturation was 86 %.
The desaturation was reversed by oxygenation. After hos-
pitalization, a physical examination showed wheezes and
hepatomegaly. Respiratory therapy with nasal continuous
positive airway pressure was started, but apnea persisted.
Laboratory ﬁndings upon admission showed increased
aspartate aminotransferase (AST), alanine aminotransfer-
ase (ALT), lactase dehydrogenase (LDH), creatine phos-
phokinase (CPK), and carbon dioxide (PaCO2) (Table 1).
AST, ALT, LDH, and CPK levels in serum increased
progressively until day 2. RSV antigen was detected in a
nasopharyngeal swab. The results of several cultures were
negative. Chest radiography and computed tomography
scans showed bilateral pulmonary inﬁltrative shadow,
atelectasis, and severe air trapping. A diagnosis of pediatric
SIRS caused by RSV infection was made based on the
published criteria for this condition [5].
The patient was intubated and ventilated immediately.
Profound sedation was used because high-pressure mechan-
ical ventilation was required. Immunomodulatory therapy
with high-dose steroids (methylprednisolone 30 mg/kg/day
for 3 days) was also initiated because the respiratory
therapies were ineffective. On day 5, there were no sig-
niﬁcant abnormalities on T1-weighted, T2-weighted, and
ﬂuid-attenuated inversion recovery magnetic resonance
imaging (MRI), but the bilateral hippocampus showed a
high signal intensity in diffusion-weighted imaging (DWI)
MRI with reduction of the apparent diffusion coefﬁcient
(ADC) (Fig. 1 a, b). An electroencephalogram (EEG) was
normal on day 5. The patient was extubated on day 7.
On day 14, the hippocampal abnormality and ADC were
improved on DWI MRI. However, on the same day, the
Table 1 Laboratory data at
admission
a Normal value or range. IL-6
was measured using Human
IL-6 CLEIA (Fujirebio, Japan).
IL-1b, IL-8, and IL-10 were
measured using BIOSOURCE
IL-1b, IL-8, and IL-10 ELISA
kits (BioSource Europe,
Nivelles, Belgium). MCP-1 and
TNF-a were measured using
Human MCP-1 and TNF-a
Immunoassay kits (R&D
Systems, Minneapolis, MN,
USA)
Peripheral blood Arterial blood gas analysis (FiO2 0.30–0.45)
WBC 20,200/ll pH 7.228
Nt 31 % PaCO2 69.4 Torr
Ly 47 % PaO2 72.7 Torr
Mo 10 % HCO3
- 27.9 mmol/l
Eo 2 % BE -0.1 mEq/l
Ba 0 % Serology
RBC 305 9 104/ll CRP 3.87 mg/dl
Hb 10.1 g/dl Procalcitonin 0.77 ng/ml
Ht 32.4 % IgG 853 mg/dl
Plt 52.7 9 104/ll IgM 32 mg/dl
Biochemistry IgA 5 mg/dl
TP 6.7 g/dl Ferritin 8163 ng/ml
Alb 4.1 g/dl IL-6 (\4 pg/ml)a 304 pg/ml
AST 192 U/l Serology during hospitalization
ALT 160 U/l IL-1b (\10 pg/ml)a \200 pg/ml
T-bil 1.3 mg/dl IL-8 (\2 pg/ml)a 115 pg/ml
LDH 1359 U/l IL-10 (\5 pg/ml)a \20 pg/ml
CK 439 U/l MCP-1 (200–722 pg/ml)a \625 pg/ml
BUN 12 mg/dl TNF-a (0.6–2.8 pg/ml)a \5 pg/ml
Cre 0.24 mg/dl Cerebral spinal ﬂuid
Na 122 mEq/l IL-6 (\0.4 pg/ml)a 102 pg/ml
K 5.8 mEq/l Viral culture (–)
Cl 89 mEq/l Protein 88 mg/dl
Glucose 55 g/dl Cell count 2/ll
Culture – –
Blood (–) – –
Spinal ﬂuid (–) – –
Nasal Haemophilus inﬂuenzae – –
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patient presented with trembling of the upper limbs from
side to side, and an EEG showed occasional unilateral
spikes in the parietal area. Therefore, anticonvulsant ther-
apy with phenobarbital was started. Serological tests for
rubella, measles, cytomegalovirus, Epstein–Barr virus,
herpes simplex virus, and autoantibodies associated with
limbic encephalitis (antibodies against the glutamate
receptor Glue2, voltage-gated potassium channel, and
Fig. 1 Magnetic resonance
imaging (MRI) on day 6.
Diffusion-weighted imaging
(DWI) (a) revealed bilateral
high-intensity regions in the
hippocampus, and the apparent
diffusion coefﬁcient (ADC)
(b) was low in the same regions.
c–f 99mTc- ethylcysteinate
dimer (ECD) single-photon
emission computed tomography
(SPECT). Axial views through
the parietal lobes (c, e) and
through the cerebral cortex,
white matter, and basal ganglia
(d, f). Upper row (c, d): At
18 days after onset (hospital day
18), SPECT showed
hypoperfusion of the bilateral
frontal and parietal lobes and
the unilateral temporal lobe with
some predominance on the left
side. Lower row (e, f): At
3 months after onset,
hypoperfusion of the bilateral
parietal lobes on SPECT had
improved, but hypoperfusion of
the unilateral temporal lobe with
some predominance on the left
side was exacerbated
980 J Infect Chemother (2013) 19:978–982
123
NR1/NR2 subunits of the N-methyl-D-aspartate receptor)
were negative during the acute phase. RSV antibody in
serum was positive (NT 916) on day 3. His mother had no
ovarian teratoma during pregnancy.
At admission, interleukin (IL)-6 was increased markedly
in the spinal ﬂuid, and IL-6 serum levels were even more
elevated compared with the spinal ﬂuid [2, 3]. In the acute
phase, serum IL-8 was signiﬁcantly and markedly
increased, but IL-1b, IL-10, monocyte chemoattractant
protein (MCP)-1, and tumor necrosis factor (TNF)-a levels
were only slightly increased or not signiﬁcantly altered
(Table 1). Therefore, the patient was diagnosed with
encephalopathy caused by RSV infection, as suggested by
a prior study showing stupor and hypotonia lasting for at
least 24 h and seizure [6]. 99mTc-labeled ethylcysteinate
dimer (ECD) SPECT on hospital day 18 showed hypo-
perfusion of the bilateral frontal and parietal regions and
the unilateral temporal region with some predominance on
the left side (Fig. 1c, d).
Follow-up EEG, MRI, and SPECT were performed
3 months after onset. EEG was normal and phenobarbital
treatment was ended. MRI did not show any signs of
atrophy. 99mTc-labeled ECD SPECT at 3 months still
showed hypoperfusion of the bilateral frontal region and
unilateral temporal region with some predominance on the
left side. Hypoperfusion on SPECT had improved in the
bilateral parietal lobes but persisted in the frontal and
temporal regions (Fig. 1e, f). The patient has no neuro-
logical deﬁcit at 6 months of age.
Discussion
The present case was diagnosed as RSV encephalopathy
accompanied by markedly increased levels of serum IL-6.
These ﬁndings are consistent with alteration of cytokine
levels in inﬂuenza virus-associated encephalopathy,
because previous studies have shown marked increases of
IL-6 in serum and spinal ﬂuid in this disease [7, 8]. In
particular, the serum IL-6 level has been suggested to be a
useful indicator for the diagnosis and clinical severity of
viral encephalopathy [7]. In our case, spinal ﬂuid IL-6 was
increased signiﬁcantly and serum IL-6 showed an even
greater increase. However, we also note that some studies
have not found increased serum IL-6 in RSV encephalop-
athy [2–4].
Our observations in this case indicate that RSV
encephalopathy can occur during SIRS. The cause of SIRS
is essentially overproduction of inﬂammatory cytokines
such as TNF-a, IL-1b, and IL-6 [9]. Thus, SIRS associated
with RSV infection may be characterized by progression of
severe pneumonia caused by hematogenous actions of
elevated IL-6 on the lung and encephalopathy of the
cytokine storm type resulting from similar actions of IL-6
on the brain. This suggestion is supported by the marked
increase in serum IL-8, which is similar to the cytokine
storm that can occur in inﬂuenza virus-associated enceph-
alopathy [10]. The elevated IL-6 levels in the spinal ﬂuid
and serum and elevated IL-8 levels in the serum suggest
that cytokine storm may be involved in the pathogenesis of
RSV encephalopathy. However, the etiology of RSV
encephalopathy is unclear. Speciﬁcally, it is uncertain
whether direct impairment of the central nervous system is
primarily responsible for the cerebral involvement in RSV
disease, or if this is caused by increased production of one
or more cytokines in cerebrospinal ﬂuid during the acute
phase [11, 12].
The characteristics of brain imaging ﬁndings in RSV
encephalopathy are also unclear. A recent report showed
that these ﬁndings often include unilateral brain hemi-
sphere abnormalities on CT, MRI, and SPECT [3, 11, 13].
Our case exhibited hypoperfusion of the bilateral hippo-
campal regions and the unilateral temporal region on
SPECT. In general, limbic encephalitis associated with
infection is most commonly caused by herpes simplex
virus, but a test for herpes simplex virus IgM antibody was
negative on day 12. Most cases of autoimmune limbic
encephalitis are indicated by autoantibodies, but in this
case these autoantibodies were negative or normal in the
acute phase [14]. Fo¨rster et al. showed that hippocampal
DWI hyperintensities and a reduction of ADC on MRI
were caused by limbic encephalitis with viral infection.
These infections included human herpesvirus 6 and herpes
simplex virus, but not RSV [15]. Therefore, this patient
was diagnosed with RSV encephalopathy without limbic
encephalitis.
After 3 months, hypoperfusion on SPECT had improved
in the bilateral parietal lobes, but persisted in the frontal
and temporal regions without neurological sequelae. Sim-
ilarly, Hirayama et al. [16] found that residual cerebellar
abnormalities on SPECT persisted 1 year after onset in
RSV encephalitis with mild ataxia. Thus, RSV encepha-
lopathy may be associated with prolonged cerebral hypo-
perfusion. Our case suggests that detection of severe RSV
infection should lead to consideration of an early diagnosis
of encephalopathy associated with SIRS.
Acknowledgments We thank Dr. Osamu Watanabe, Department of
Neurology and Geriatrics, Kagoshima University Graduate School of
Medical and Dental Sciences, for measurement of antibodies to the
voltage-gated potassium channel; Dr. Yukitoshi Takahashi, National
Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological
Disorders, for measurement of antibodies to the glutamate receptor
Glue2; Dr. Keiko Tanaka, Department of Neurology, Kanazawa
Medical University, for measurement of antibodies to the NR1/NR2
subunits of N-methyl-D-aspartate receptor; and Dr. Hidemitsu Ku-
rosawa, Department of Pediatrics, Dokkyo Medical University, for his
helpful comments on the therapy.
J Infect Chemother (2013) 19:978–982 981
123
Conﬂict of interest The authors declare no conﬂicts of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Ng YT, Cox C, Atkins J, Butler IJ. Encephalopathy associated
with respiratory syncytial virus bronchiolitis. J Child Neurol.
2001;16:105–8.
2. Morichi S, Kawashima H, Ioi H, Yamanaka G, Kashiwagi Y,
Hoshika A, et al. Classiﬁcation of acute encephalopathy in
respiratory syncytial virus infection. J Infect Chemother. 2011;
17:776–81.
3. Otake Y, Yamagata T, Morimoto Y, Imi M, Mori M, Aihara T,
et al. Elevated CSF IL-6 in a patient with respiratory syncytial
virus encephalopathy. Brain Dev. 2007;29:117–20.
4. Kawashima H, Kashiwagi Y, Ioi H, Morichi S, Oana S, Yama-
naka G, et al. Production of chemokines in respiratory syncytial
virus infection with central nervous system manifestations.
J Infect Chemother 2012 (in press)
5. Goldstein B, Giroir B, Randolph A. International pediatric sepsis
consensus conference: deﬁnitions for sepsis and organ dysfunc-
tion in pediatrics. Pediatr Crit Care Med. 2005;6:2–8.
6. Antonucci R, Chiappe S, Porcella A, Rosatelli D, Fanos V.
Bronchiolitis-associated encephalopathy in critically-ill infants:
an underestimated complication? J Matern Fetal Neonatal Med.
2010;23:431–6.
7. Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of
serum interleukin-6 level in inﬂuenza virus-associated encepha-
lopathy. Neurology. 2001;57:295–9.
8. Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T,
Furukawa S. Cerebrospinal ﬂuid and serum levels of cytokines
and soluble tumor necrosis factor receptor in inﬂuenza virus-
associated encephalopathy. Scand J Infect Dis. 2003;35:59–61.
9. Herzum I, Renz H. Inﬂammatory markers in SIRS, sepsis and
septic shock. Curr Med Chem. 2008;15:581–7.
10. Nunoi H, Mercado MR, Mizukami T, Okajima K, Morishima T,
Sakata H, et al. Apoptosis under hypercytokinemia is a possible
pathogenesis in inﬂuenza-associated encephalopathy. Pediatr Int.
2005;47:175–9.
11. Kawashima H, Ioi H, Ushio M, Yamanaka G, Matsumoto S,
Nakayama T. Cerebrospinal ﬂuid analysis in children with sei-
zures from respiratory syncytial virus infection. Scand J Infect
Dis. 2009;41:228–31.
12. Eisenhut M. Cerebral involvement in respiratory syncytial virus
disease. Brain Dev. 2007;29:454.
13. Millichap JJ, Wainwright MS. Neurological complications of
respiratory syncytial virus infection: case series and review of
literature. J Child Neurol. 2009;24:1499–503.
14. Sakuma H, Sugai K, Sasaki M. Acute nonparaneoplastic limbic
encephalitis in childhood: a case series in Japan. Pediatr Neurol.
2010;43:167–72.
15. Fo¨rster A, Griebe M, Gass A, Kern R, Hennerici MG, Szabo K.
Diffusion-weighted imaging for the differential diagnosis of
disorders affecting the hippocampus. Cerebrovasc Dis. 2011;33:
104–15.
16. Hirayama K, Sakazaki H, Murakami S, Yonezawa S, Fujimoto K,
Seto T, et al. Sequential MRI, SPECT and PET in respiratory
syncytial virus encephalitis. Pediatr Radiol. 1999;29:282–6.
982 J Infect Chemother (2013) 19:978–982
123
